These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
518 related articles for article (PubMed ID: 26875911)
1. Newer antifungal agents micafungin and voriconazole for fungal infection prevention during hematopoietic cell transplantation: a meta-analysis. Xu SX; Shen JL; Tang XF; Feng B; Xu HQ Eur Rev Med Pharmacol Sci; 2016; 20(2):381-90. PubMed ID: 26875911 [TBL] [Abstract][Full Text] [Related]
2. Newer antifungal agents for fungal infection prevention during hematopoietic cell transplantation: a meta-analysis. Xu SX; Shen JL; Tang XF; Feng B Transplant Proc; 2013; 45(1):407-14. PubMed ID: 23375330 [TBL] [Abstract][Full Text] [Related]
3. Systemic antifungal prophylaxis after hematopoietic stem cell transplantation: a meta-analysis. Ziakas PD; Kourbeti IS; Mylonakis E Clin Ther; 2014 Feb; 36(2):292-306.e1. PubMed ID: 24439393 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of echinocandins versus triazoles for the prophylaxis and treatment of fungal infections: a meta-analysis of RCTs. Wang JF; Xue Y; Zhu XB; Fan H Eur J Clin Microbiol Infect Dis; 2015 Apr; 34(4):651-9. PubMed ID: 25502737 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of micafungin versus extensive azoles in the prevention and treatment of invasive fungal infections for neutropenia patients with hematological malignancies: A meta-analysis of randomized controlled trials. Lee CH; Lin JC; Ho CL; Sun M; Yen WT; Lin C PLoS One; 2017; 12(7):e0180050. PubMed ID: 28700646 [TBL] [Abstract][Full Text] [Related]
6. Multicenter, randomized, open-label study comparing the efficacy and safety of micafungin versus itraconazole for prophylaxis of invasive fungal infections in patients undergoing hematopoietic stem cell transplant. Huang X; Chen H; Han M; Zou P; Wu D; Lai Y; Huang H; Chen X; Liu T; Zhu H; Wang J; Hu J Biol Blood Marrow Transplant; 2012 Oct; 18(10):1509-16. PubMed ID: 22469884 [TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness analysis of micafungin versus fluconazole for prophylaxis of invasive fungal infections in patients undergoing hematopoietic stem cell transplantation in Korea. Sohn HS; Lee TJ; Kim J; Kim D Clin Ther; 2009 May; 31(5):1105-15; discussion 1066-8. PubMed ID: 19539111 [TBL] [Abstract][Full Text] [Related]
8. Comparison of micafungin and voriconazole as empirical antifungal therapies in febrile neutropenic patients with hematological disorders: a randomized controlled trial. Oyake T; Kowata S; Murai K; Ito S; Akagi T; Kubo K; Sawada K; Ishida Y Eur J Haematol; 2016 Jun; 96(6):602-9. PubMed ID: 26216048 [TBL] [Abstract][Full Text] [Related]
9. Treatment of invasive candidal infections: systematic review and meta-analysis. Gafter-Gvili A; Vidal L; Goldberg E; Leibovici L; Paul M Mayo Clin Proc; 2008 Sep; 83(9):1011-21. PubMed ID: 18775201 [TBL] [Abstract][Full Text] [Related]
10. Comparison of micafungin and voriconazole in the treatment of invasive fungal infections in kidney transplant recipients. Shang W; Feng G; Sun R; Wang X; Liu W; Zhang S; Li J; Pang X; Wang Y; Zhang W J Clin Pharm Ther; 2012 Dec; 37(6):652-6. PubMed ID: 22725946 [TBL] [Abstract][Full Text] [Related]
11. An open-label trial of the prophylactic administration of voriconazole in patients who undergo allogeneic hematopoietic stem cell transplantation: study protocol. Kunitomi A; Hasegawa Y; Hashimoto H; Saito AM; Iida H Nagoya J Med Sci; 2018 Nov; 80(4):591-595. PubMed ID: 30587873 [TBL] [Abstract][Full Text] [Related]
12. Fluconazole versus itraconazole for antifungal prophylaxis in neutropenic patients with haematological malignancies: a meta-analysis of randomised-controlled trials. Vardakas KZ; Michalopoulos A; Falagas ME Br J Haematol; 2005 Oct; 131(1):22-8. PubMed ID: 16173959 [TBL] [Abstract][Full Text] [Related]
13. Randomized trial of micafungin versus fluconazole as prophylaxis against invasive fungal infections in hematopoietic stem cell transplant recipients. Park S; Kim K; Jang JH; Kim SJ; Kim WS; Chung DR; Kang CI; Peck KR; Jung CW J Infect; 2016 Nov; 73(5):496-505. PubMed ID: 27394404 [TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness analysis of antifungal prophylaxis in patients undergoing hematopoietic stem cell transplantation. Schonfeld W; Wang Cheng J; Tong KB; Seifeldin R Clin Ther; 2008 May; 30(5):964-73. PubMed ID: 18555943 [TBL] [Abstract][Full Text] [Related]
15. Network Meta-analysis and Pharmacoeconomic Evaluation of Fluconazole, Itraconazole, Posaconazole, and Voriconazole in Invasive Fungal Infection Prophylaxis. Zhao YJ; Khoo AL; Tan G; Teng M; Tee C; Tan BH; Ong B; Lim BP; Chai LY Antimicrob Agents Chemother; 2016 Jan; 60(1):376-86. PubMed ID: 26525782 [TBL] [Abstract][Full Text] [Related]
16. Voriconazole versus amphotericin B or fluconazole in cancer patients with neutropenia. Jørgensen KJ; Gøtzsche PC; Dalbøge CS; Johansen HK Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD004707. PubMed ID: 24563222 [TBL] [Abstract][Full Text] [Related]
17. [Future role of micafungin in the treatment of invasive mycoses caused by filamentous fungi]. Salavert-Lletí M; Zaragoza-Crespo R Rev Iberoam Micol; 2009 Mar; 26(1):81-9. PubMed ID: 19463284 [TBL] [Abstract][Full Text] [Related]
18. Comparison of Efficacy and Safety of Caspofungin Versus Micafungin in Pediatric Allogeneic Stem Cell Transplant Recipients: A Retrospective Analysis. Maximova N; Schillani G; Simeone R; Maestro A; Zanon D Adv Ther; 2017 May; 34(5):1184-1199. PubMed ID: 28429246 [TBL] [Abstract][Full Text] [Related]
19. Sequential systematic anti-mold prophylaxis with micafungin and voriconazole results in very low incidence of invasive mold infections in patients undergoing allogeneic hematopoietic stem cell transplantation. Rosillo C; Avila AM; Huang YT; Devlin S; Cho C; Montoro J; Maloy MA; Papanicolaou GA; Barba P; Perales MA Transpl Infect Dis; 2018 Aug; 20(4):e12897. PubMed ID: 29668073 [TBL] [Abstract][Full Text] [Related]
20. Randomized trial of micafungin for the prevention of invasive fungal infection in high-risk liver transplant recipients. Saliba F; Pascher A; Cointault O; Laterre PF; Cervera C; De Waele JJ; Cillo U; Langer RM; Lugano M; Göran-Ericzon B; Phillips S; Tweddle L; Karas A; Brown M; Fischer L; ; Clin Infect Dis; 2015 Apr; 60(7):997-1006. PubMed ID: 25520332 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]